You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gene Mutation

Showing 1 - 25 of 9,290
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

Recruiting
  • ARID1A Gene Mutation
  • +15 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Gene Mutation Trial in Beijing (RAG-17)

Enrolling by invitation
  • Gene Mutation
  • Beijing, China
    Beijing Tiantan Hospital
Jun 11, 2023

Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

Recruiting
  • Her-2 Negative Breast Cancer
  • HRR Gene Mutation
  • Guangzhou, Guangdong, China
    First Affiliated Hospital, Sun Yat-Sen University
Mar 7, 2023

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

    Not yet recruiting
    • AXIN1 Gene Mutation
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Colorectal Carcinoma, Liver Metastases Trial in Shanghai (anatomical liver resection, nonanatomical liver resection)

    Not yet recruiting
    • Colorectal Carcinoma
    • Liver Metastases
    • anatomical liver resection
    • nonanatomical liver resection
    • Shanghai, Shanghai, China
      Zhongshan hospital
    May 21, 2023

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Lynch Syndrome, Lynch Syndrome I, Lynch Syndrome II Trial in Milan (Video capsule endoscopy)

    Recruiting
    • Lynch Syndrome
    • +7 more
    • Video capsule endoscopy
    • Milan, Lombardia, Italy
      San Raffaele Scientific Institute, Gastroenterology and Gastroin
    Jan 27, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

    Recruiting
    • BARD1 Gene Mutation
    • +14 more
    • Educational Intervention
    • +3 more
    • Houston, Texas
    • +1 more
    Jun 14, 2022

    Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)

    Not yet recruiting
    • Cancer
    • +2 more
    • Pan-genomic Testing
    • Scottsdale, Arizona
    • +2 more
    Aug 18, 2023

    Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

    Recruiting
    • Metastatic Solid Tumor
    • +4 more
    • Recommendation for treatment with immunotherapy
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 8, 2022

    TRPV4 Gene Mutation Trial

    Not yet recruiting
    • TRPV4 Gene Mutation
      • (no location specified)
      Jan 9, 2023

      Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

      Recruiting
      • Cancer
      • +6 more
      • Indianapolis, Indiana
        Indiana University Hospital / IU Simon Cancer Center
      Jan 12, 2023

      Bile Acids in Acute Insulin Resistance

      Recruiting
      • PI3K Gene Mutation
      • +4 more
      • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
      • New York, New York
        Columbia University Medical Center
      Oct 6, 2022

      Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit

      Not yet recruiting
      • Helicobacter Pylori Infection
      • +3 more
      • Detection of fecal samples with diagnostic kit
      • +2 more
      • (no location specified)
      Jun 5, 2022

      DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

      Not yet recruiting
      • DDX41 Gene Mutation
      • For each person (index case or related) included in this study:
      • Bordeaux, France
      • +4 more
      Aug 28, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation Trial in Netherlands (Risk-reducing salpingectomy with delayed

      Recruiting
      • BRCA1 Gene Mutation
      • +5 more
      • Risk-reducing salpingectomy with delayed oophorectomy
      • Risk-reducing salpingo-oophorectomy
      • Tilburg, Brabant, Netherlands
      • +13 more
      Nov 1, 2022

      Patients With a Constitutional Alteration of the PTEN Gene

      Not yet recruiting
      • PTEN Gene Mutation
        • (no location specified)
        Nov 17, 2022

        Factors Influencing Cascade Testing Among Hereditary

        Recruiting
        • Breast Carcinoma
        • +8 more
        • Interview
        • +2 more
        • Birmingham, Alabama
        • +1 more
        Jun 22, 2022

        Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

        Active, not recruiting
        • Deleterious BARD1 Gene Mutation
        • +13 more
        • Laboratory Biomarker Analysis
        • +4 more
        • Chicago, Illinois
        • +8 more
        Feb 25, 2022

        EMPHYSEMA AND FLNA MUTATION

        Not yet recruiting
        • Emphysema
        • Chest HRCT
        • +2 more
        • (no location specified)
        Sep 19, 2022

        NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +32 more
        • (no location specified)
        Mar 30, 2023